Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023

  • ID: 4495792
  • Report
  • Region: Global
  • 226 pages
  • Markets and Markets
1 of 6
The Stem Cell Assay Market is Expected to Reach USD 1,978.7 Million by 2023 from USD 791.9 Million in 2018

FEATURED COMPANIES

  • Agilent Technologies
  • Bio-Techne Corporation
  • GE Healthcare
  • Merck
  • Perkinelmer
  • Stemcell Technologies
  • MORE

“The global stem cell assay market projected to grow at a CAGR of 20.1% during the forecast period.”

The stem cell assay market is expected to reach USD 1,978.7 million by 2023 from USD 791.9 million in 2018, at a CAGR of 20.1%. The availability of funding for stem cell research; rising incidence of target indications; technological advancements in stem cell research instruments and the introduction of novel stem cell products; and the growth of end-use industries are the major factors driving the growth of this market. On the other hand, ethical issues related to embryonic stem cell research and the high cost of stem cell analysis instruments and reagents are factors expected to restrain the growth of this market to a certain extent.

“By type, the isolation & purification segment is anticipated to grow at the highest growth rate during the forecast period.”

This market is categorized by type into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function, and apoptosis assays. The isolation & purification segment is estimated to grow at the highest rate during the forecast period. The rising demand for stem cell isolation assays in biotechnology and biopharmaceutical companies for drug development processes is driving the growth of this segment.

“Biopharmaceutical & biotechnology companies to dominate the end-user market during the forecast period.”

By end user, the stem cell assay market is segmented into biopharmaceutical & biotechnology companies; and research institutes. The biopharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. Stem cell assays are widely used by biopharmaceutical & biotechnology companies for drug screening and development and cell analysis, which is the key factor driving the growth of this end-user segment in this market.

“North America is estimated to grow at the highest CAGR during the study period.”

In 2017, the stem cell assay market was dominated by North America; and also estimated to grow at the Higest growth rate during the forecast period. The growth of this segment can be attributed to the increasing availability of grants and funding from governments as well as the rising use of stem cells for personalized medicine and drug discovery & development. Moreover, the growth of the biotechnology and pharmaceutical industry and rising incidence of cancer are also contributing to market growth in North America.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 60%, Tier 2 - 20% and Tier 3 - 20%
  • By Designation - C-level - 40%, Director-level - 20%, Others - 40%
  • By Region - North America - 50%, Europe - 20%, Asia Pacific- 30%

The key players in the stem cell assay market include Merck (Germany), GE Healthcare (US), Agilent Technologies (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Cell Biolabs (US), PerkinElmer (US), Promega Corporation (US), Miltenyi Biotec (Germany), Bio-Techne Corporation (US), HemoGenix (US), STEMCELL Technologies (Canada), and Cellular Dynamics International (US).

Research Coverage:
The report analyses the stem cell assay market by type, cell type, product & service, application, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms to garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned strategies to strengthen their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the stem cell assay market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the stem cell assay market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the stem cell assay market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various stem cell assays across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the stem cell assay market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Agilent Technologies
  • Bio-Techne Corporation
  • GE Healthcare
  • Merck
  • Perkinelmer
  • Stemcell Technologies
  • MORE

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
    4.1 Stem Cell Assays Market Overview
    4.2 Asia Pacific: Stem Cell Assays Market, By Instrument & Country
    4.3 Stem Cell Assays Market, By Type
    4.4 Geographical Snapshot of the Stem Cell Assays Market (By Major Countries)

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Availability of Funding for Stem Cell Research
                    5.2.1.2 Rising Incidence of Target Indications
                    5.2.1.3 Technological Advancements in Stem Cell-Based Research Instruments and Introduction of Novel Stem Cell Products
                    5.2.1.4 Growth of End-Use Industries
           5.2.2 Restraints
                    5.2.2.1 Ethical Issues Related to Embryonic Stem Cell Research
                    5.2.2.2 High Cost of Stem Cell Analysis Instruments and Reagents
           5.2.3 Opportunities
                    5.2.3.1 Growth Opportunities in Emerging Economies
                    5.2.3.2 Emergence of Microfluidics in Stem Cell Research
                    5.2.3.3 High Growth Potential of Single Stem Cell Analysis Sequencing
           5.2.4 Challenges
                    5.2.4.1 Complexities Related to Antibody and Reagent Development
                    5.2.4.2 Survival of Small Players and New Entrants
    5.3 Technology Roadmap
           5.3.1 Microfabrication-Assisted Technologies
                    5.3.1.1 Microfluidics-Based Cell Trap Technology
                    5.3.1.2 Droplet-Based Microfluidic Technology
                    5.3.1.3 Microwell-Based Analysis Systems
           5.3.2 Advanced Technology
                    5.3.2.1 Bead-Based Multiplex Assays

6 Stem Cell Assays Market, By Type
    6.1 Introduction
    6.2 Viability/Cytotoxicty Assays
    6.3 Isolation & Purification Assays
    6.4 Cell Identification Assays
    6.5 Proliferation Assays
    6.6 Differentiation Assays
    6.7 Function Assays
    6.8 Apoptosis Assays

7 Stem Cell Assays Market, By Cell Type
    7.1 Introduction
    7.2 Adult Stem Cells
           7.2.1 Adult Stem Cells Market, By Type
                    7.2.1.1 Mesenchymal Stem Cells
                    7.2.1.2 Induced Pluripotent Stem Cells
                    7.2.1.3 Hematopoietic Stem Cells
                    7.2.1.4 Umbilical Cord Stem Cells
                    7.2.1.5 Neural Stem Cells
    7.3 Human Embryonic Stem Cells

8 Stem Cell Assays Market, By Product & Service
    8.1 Introduction
    8.2 Instruments
           8.2.1 Instruments Market, By Type
                    8.2.1.1 Flow Cytometers
                    8.2.1.2 Microelectrode Arrays
                    8.2.1.3 Cell Imaging Systems
                    8.2.1.4 Automated Cell Counters
    8.3 Kits
    8.4 Services

9 Stem Cell Assays Market, By Application
    9.1 Introduction
    9.2 Regenerative Medicine & Therapy Development
           9.2.1 Orthopedic & Musculoskeletal Spine Applications
           9.2.2 Dermatology
           9.2.3 Cardiovascular Applications
           9.2.4 Central Nervous System Applications
           9.2.5 Oncology
           9.2.6 Diabetes
           9.2.7 Other Applications
    9.3 Drug Discovery & Development
    9.4 Clinical Research

10 Stem Cell Assays Market, By End User
     10.1 Introduction
     10.2 Biopharmaceutical & Biotechnology Companies
     10.3 Research Institutes

11 Global Stem Cell Assays Market, By Region
     11.1 Introduction
     11.2 North America
             11.2.1 US
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 UK
             11.3.3 France
             11.3.4 Spain
             11.3.5 Italy
             11.3.6 Switzerland
             11.3.7 Rest of Europe (RoE)
     11.4 Asia Pacific
             11.4.1 China
             11.4.2 Japan
             11.4.3 India
             11.4.4 Rest of Asia Pacific
     11.5 Rest of the World

12 Competitive Landscape
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends
             12.3.1 Product Launches
             12.3.2 Partnerships & Agreements
             12.3.3 Acquisitions
             12.3.4 Expansions

13 Company Profiles
(Business Overview, Products Offered, Recent Developments, Author's View)*
     13.1 Thermo Fisher Scientific
     13.2 Merck
     13.3 GE Healthcare
     13.4 Bio-Rad Laboratories
     13.5 Promega Corporation
     13.6 Agilent Technologies
     13.7 Perkinelmer
     13.8 Miltenyi Biotec
     13.9 Cell Biolabs
     13.10 Hemogenix
     13.11 Stemcell Technologies
     13.12 Bio-Techne Corporation
     13.13 Cellular Dynamics International (CDI)

*Business Overview, Products Offered, Recent Developments, Author's View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix
     14.1 Industry Insights
     14.2 Discussion Guide

List of Tables

Table 1 List of Diseases That Can Be Treated Using Stem Cells
Table 2 Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 3 Viability/Cytotoxicty Assays Market, By Region, 2016–2023 (USD Million)
Table 4 Isolation & Purification Assays Market, By Region, 2016–2023 (USD Million)
Table 5 Cell Identification Assays Market, By Region, 2016–2023 (USD Million)
Table 6 Proliferation Assays Market, By Region, 2016–2023 (USD Million)
Table 7 Differentiation Assays Market, By Region, 2016–2023 (USD Million)
Table 8 Function Assays Market, By Region, 2016–2023 (USD Million)
Table 9 Apoptosis Assays Market, By Region, 2016–2023 (USD Million)
Table 10 Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 11 Adult Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 12 Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 13 Mesenchymal Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 14 Induced Pluripotent Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 15 Hematopoietic Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 16 Umbilical Cord Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 17 Neural Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 18 Human Embryonic Stem Cells Market, By Region, 2016–2023 (USD Million)
Table 19 Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 20 Stem Cell Assay Instruments Market, By Region, 2016–2023 (USD Million)
Table 21 Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 22 Flow Cytometers Market, By Region, 2016–2023 (USD Million)
Table 23 Microelectrode Arrays Market, By Region, 2016–2023 (USD Million)
Table 24 Cell Imaging Systems Market, By Region, 2016–2023 (USD Million)
Table 25 Automated Cell Counters Market, By Region, 2016–2023 (USD Million)
Table 26 Stem Cell Assay Kits Market, By Region, 2016–2023 (USD Million)
Table 27 Stem Cell Assay Services Market, By Region, 2016–2023 (USD Million)
Table 28 Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 29 Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Region, 2016–2023 (USD Million)
Table 30 Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 31 Orthopedic & Musculoskeletal Spine Applications Market, By Region, 2016–2023 (USD Million)
Table 32 Dermatology Applications Market, By Region, 2016–2023 (USD Million)
Table 33 Cardiovascular Applications Market, By Region, 2016–2023 (USD Million)
Table 34 Central Nervous System Applications Market, By Region, 2016–2023 (USD Million)
Table 35 Oncology Applications Market, By Region, 2016–2023 (USD Million)
Table 36 Diabetes Applications Market, By Region, 2016–2023 (USD Million)
Table 37 Other Regenerative Medicine & Therapy Development Applications Market, By Region, 2016–2023 (USD Million)
Table 38 Stem Cell Assays Market for Drug Discovery & Development, By Region, 2016–2023 (USD Million)
Table 39 Stem Cell Assays Market for Clinical Research, By Region, 2016–2023 (USD Million)
Table 40 Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 41 Stem Cell Assays Market for Biopharmaceutical & Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 42 Stem Cell Assays Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 43 Stem Cell Assays Market, By Region, 2016–2023 (USD Million)
Table 44 North America: Stem Cell Assays Market, By Country, 2016–2023 (USD Million)
Table 45 North America: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 46 North America: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 47 North America: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 48 North America: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 49 North America: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 50 North America: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 51 North America: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 52 North America: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 53 Incidence & Prevalence of Target Diseases (2017)
Table 54 Timelines of Major Events in Stem Cell Research Policy (2011 - 2017)
Table 55 US: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 56 US: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 57 US: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 58 US: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 59 US: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 60 US: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 61 US: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 62 US: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 63 Canada: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 64 Canada: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 65 Canada: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 66 Canada: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 67 Canada: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 68 Canada: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 69 Canada: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 70 Canada: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 71 Europe: Stem Cell Assays Market, By Country, 2016–2023 (USD Million)
Table 72 Europe: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 73 Europe: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 74 Europe: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 75 Europe: Stem Cell Assays Market, By Product and Service, 2016–2023 (USD Million)
Table 76 Europe: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 77 Europe: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 78 Europe: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 79 Europe: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 80 Germany: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 81 Germany: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 82 Germany: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 83 Germany: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 84 Germany: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 85 Germany: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 86 Germany: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 87 Germany: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 88 UK: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 89 UK: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 90 UK: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 91 UK: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 92 UK: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 93 UK: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 94 UK: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 95 UK: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 96 France: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 97 France: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 98 France: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 99 France: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 100 France: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 101 France: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 102 France: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 103 France: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 104 Spain: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 105 Spain: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 106 Spain: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 107 Spain: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 108 Spain: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 109 Spain: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 110 Spain: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 111 Spain: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 112 Italy: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 113 Italy: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 114 Italy: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 115 Italy: Stem Cell Assays Market, By Product & Service 2016–2023 (USD Million)
Table 116 Italy: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 117 Italy: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 118 Italy: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 119 Italy: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 120 Switzerland: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 121 Switzerland: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 122 Switzerland: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 123 Switzerland: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 124 Switzerland: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 125 Switzerland: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 126 Switzerland: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 127 Switzerland: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 128 RoE: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 129 RoE: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 130 RoE: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 131 RoE: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 132 RoE: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 133 RoE: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 134 RoE: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 135 RoE: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 136 Asia Pacific: Stem Cell Assays Market, By Country, 2016–2023 (USD Million)
Table 137 Asia Pacific: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 138 Asia Pacific: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 139 Asia Pacific: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 140 Asia Pacific: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 141 Asia Pacific: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 142 Asia Pacific: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 143 Asia Pacific: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 144 Asia Pacific: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 145 China: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 146 China: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 147 China: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 148 China: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 149 China: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 150 China: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 151 China: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 152 China: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 153 Japan: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 154 Japan: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 155 Japan: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 156 Japan: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 157 Japan: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 158 Japan: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 159 Japan: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 160 Japan: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 161 India: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 162 India: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 163 India: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 164 India: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 165 India: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 166 India: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 167 India: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 168 India: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 169 RoAPAC: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 170 RoAPAC: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 171 RoAPAC: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 172 RoAPAC: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 173 RoAPAC: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 174 RoAPAC: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 175 RoAPAC: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 176 RoAPAC: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 177 RoW: Stem Cell Assays Market, By Type, 2016–2023 (USD Million)
Table 178 RoW: Stem Cell Assays Market, By Cell Type, 2016–2023 (USD Million)
Table 179 RoW: Adult Stem Cells Market, By Type, 2016–2023 (USD Million)
Table 180 RoW: Stem Cell Assays Market, By Product & Service, 2016–2023 (USD Million)
Table 181 RoW: Stem Cell Assay Instruments Market, By Type, 2016–2023 (USD Million)
Table 182 RoW: Stem Cell Assays Market, By Application, 2016–2023 (USD Million)
Table 183 RoW: Stem Cell Assays Market for Regenerative Medicine & Therapy Development, By Type, 2016–2023 (USD Million)
Table 184 RoW: Stem Cell Assays Market, By End User, 2016–2023 (USD Million)
Table 185 Product Launches, 2014–2017
Table 186 Partnerships and Agreements, 2014–2017
Table 187 Acquisitions, 2014–2017
Table 188 Expansions, 2014–2017

List of Figures

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Stem Cell Assays Market, By Type, 2018 vs 2023 (USD Billion)
Figure 7 Stem Cell Assays Market, By Cell Type, 2018 vs 2023 (USD Billion)
Figure 8 Stem Cell Assays Market, By Product & Service, 2018 vs 2023 (USD Billion)
Figure 9 Stem Cell Assays Market, By Application, 2018 vs 2023 (USD Billion)
Figure 10 Stem Cell Assays Market, By End User, 2018 vs 2023 (USD Billion)
Figure 11 Stem Cell Assays Market, By Region, 2018 vs 2023 (USD Billion)
Figure 12 Availability of Funding for Stem Cell Research to Drive Market Growth During the Forecast Period
Figure 13 Flow Cytometers Accounted for the Largest Market Share in 2017
Figure 14 Isolation & Purification Assays to Register the Highest CAGR During the Forecast Period
Figure 15 Canada to Register the Highest CAGR During the Forecast Period
Figure 16 Stem Cell Assays Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 NIH Funding for Stem Cell Research in the Us, 2013 vs 2016 (USD Million)
Figure 18 Viability/Cytotoxicity Assays to Dominate the Market During the Forecast Period
Figure 19 Adult Stem Cells Segment to Dominate the Market During the Forecast Period
Figure 20 Mesenchymal Stem Cells Segment to Dominate the Market During the Forecast Period
Figure 21 Stem Cell Assay Instruments to Dominate the Market During the Forecast Period
Figure 22 Flow Cytometers to Dominate the Market During the Forecast Period
Figure 23 Regenerative Medicine & Therapy Development Segment to Dominate the Market During the Forecast Period
Figure 24 Biopharmaceutical & Biotechnology Companies to Dominate the Stem Cell Assays Market in 2023
Figure 25 North America to Dominate the Global Stem Cell Assays Market in 2018
Figure 26 North America: Stem Cell Assays Market Snapshot
Figure 27 Viability/Cytotoxicity Segment to Dominate the North American Stem Cell Assays Market in 2018
Figure 28 Europe: Stem Cell Assays Market Snapshot
Figure 29 Adult Stem Cells Segment to Dominate the European Stem Cell Assays Market in 2018
Figure 30 Asia Pacific: Stem Cell Assays Market Snapshot
Figure 31 Instruments Segment to Dominate the Asia Pacific Stem Cell Assays Market in 2018
Figure 32 RoW: Stem Cell Assays Market Snapshot
Figure 33 Regenerative Medicine & Therapy Development Segment to Dominate the RoW Stem Cell Assays Market in 2018
Figure 34 Market Share Analysis - 2016
Figure 35 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 36 Merck: Company Snapshot (2016)
Figure 37 GE Healthcare: Company Snapshot (2016)
Figure 38 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 39 Agilent Technologies: Company Snapshot (2017)
Figure 40 Perkinelmer: Company Snapshot (2016)
Figure 41 Bio-Techne Corporation: Company Snapshot (2017)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Cell Biolabs
  • Cellular Dynamics International (CDI)
  • GE Healthcare
  • Hemogenix
  • Merck
  • Miltenyi Biotec
  • Perkinelmer
  • Promega Corporation
  • Stemcell Technologies
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll